We fully support the consensus statement on designing clinical trials to address alcohol use in people with alcohol-associated liver disease (ALD), which aims to standardize and improve the design of ALD trials (Lee, B. P. et al. Designing clinical trials to address alcohol use and alcohol-associated liver disease: an expert panel Consensus Statement. Nat. Rev. Gastroenterol. Hepatol. 21, 626–645 (2024))¹. The authors highlight the global burden of ALD and the paucity of clinical trials of interventions to reduce or eliminate alcohol use in people with alcohol use disorder (AUD) — a set of recommendations for this field is crucial.

我们完全支持关于设计临床试验以解决酒精相关性肝病 （ALD） 患者饮酒问题的共识声明，该声明旨在标准化和改进 ALD 试验的设计（Lee， BP 等人设计临床试验以解决酒精使用和酒精相关性肝病：专家小组共识声明。Nat. Rev. 胃肠醇。肝醇。21， 626–645 （2024））¹.作者强调了酒精性肝病的全球负担以及缺乏减少或消除酒精使用障碍 （AUD） 患者饮酒的干预措施的临床试验——针对该领域的一系列建议至关重要。